An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA

Lancet

Volumn 349, Issue 9052, 1997, Pages 604-608

  Lurie, Peter ^a   Drucker, Ernest ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG ABUSE; FINANCE; GOVERNMENT; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEEDLE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; UNITED STATES;

EID: 0031040886     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)05439-6     Document Type: Article

References (27)

1. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996; 86: 642-54.
2. Normand J, Vlahov D, Moses LE, eds. Preventing HIV transmission: the role of sterile needles and bleach. National Research Council/Institute of Medicine. Washington, DC: National Academy Press, 1995.
3. Lurie P, Reingold AL, eds. The public health impact of needle exchange programs in the United States and abroad, volume I. University of California, 1993.
4. Brachman PS. Transmission and principles of control. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infections diseases, 2nd edn. New York: John Wiley & Sons, 1985.
5. General Accounting Office. Needle exchange programs: research suggests promise as an AIDS prevention strategy (GAO/HRD-93-60). Washington, DC: US Government Printing Office, 1993.
6. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma Syringe Exchange Program. Am J Public Health 1995; 85: 1531-37.
7. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995; 274: 1226-31.
8. Kaplan EH. A method for evaluating needle exchange programmes. Stats Med 1994; 13: 2179-87.
9. National Commission on Acquired Immune Deficiency Syndrome. The twin epidemics of substance use and HIV. Washington, DC, 1991.
10. Satcher D. Note to Jo Ivey Boufford, Dec 10, 1993. Available from the Drug Policy Foundaton, 4455 Connecticut Avenue, NW, Suite B-500, Washington, DC, 20008, USA.
11. Office of Technology Assessment. The effectiveness AIDS prevention efforts. Washington, DC, 1995.
12. Centers for Disease Control. HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop. MMWR 1990; 39 (no 16): 8.
13. Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989; 261: 1008-12.
14. Kaplan EH. Probability models of needle exchange. Op Res 1995; 43: 558-69.
15. Loxley W, Carruthers S, Bevan J. In the same vein: first report of the Australian study of HIV and injecting drug use. National Centre for Research into the Prevention of Drug Abuse, Curtin University of Technology. Perth, 1995.
16. Australian National AIDS and Injecting Drug Use Study. Neither a borrower nor a lender be: first report of the Australian National AIDS and Injecting Drug Use Study: Sydney, 1991.
17. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1994; 6: 10.
18. Guinan ME, Farnham PG, Holtgrave DR. Estimating the value of preventing a human immunodeficiency virus infection. Am J Prev Med 1994; 10: 1-4.
19. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348: 987-91.
20. Waldholz M. New York City's health unit urges easier syringe rule. Wall Street Journal Sept 3, 1985: A-14.
21. Van den Hoek JA, van Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989; 79: 1355-57.
22. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994; 271: 115-20.
23. Paone D, Des Jarlais DC, Clark J, et al. Syringe exchange programs - United States, 1994-1995. MMWR 1995; 44: 684-85.
24. Feachem RGA. Valuing the past. . .investing in the future. Commonwealth Department of Human Services and Health. Canberra: Australian Government Publishing Service, 1995.
25. Lurie P. When science and politics collide: the federal response to needle-exchange programs. Bull NY Acad Med 1995; 72: 380-96.
26. Anon. The Kaiser survey on Americans and AIDS/HIV. Henry J Kaiser Family Foundation, Menlo Park, CA, March 26, 1996.
27. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers - Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 82-89.